FR2329275A1 - Triazoles substitues - Google Patents

Triazoles substitues

Info

Publication number
FR2329275A1
FR2329275A1 FR7632136A FR7632136A FR2329275A1 FR 2329275 A1 FR2329275 A1 FR 2329275A1 FR 7632136 A FR7632136 A FR 7632136A FR 7632136 A FR7632136 A FR 7632136A FR 2329275 A1 FR2329275 A1 FR 2329275A1
Authority
FR
France
Prior art keywords
alkyl
phenyl
substd
ring
halogens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7632136A
Other languages
English (en)
Other versions
FR2329275B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeneca Inc
Original Assignee
ICI Americas Inc
ICI United States Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ICI Americas Inc, ICI United States Inc filed Critical ICI Americas Inc
Publication of FR2329275A1 publication Critical patent/FR2329275A1/fr
Application granted granted Critical
Publication of FR2329275B1 publication Critical patent/FR2329275B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/18—Benzotriazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR7632136A 1975-10-28 1976-10-25 Triazoles substitues Granted FR2329275A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62614075A 1975-10-28 1975-10-28

Publications (2)

Publication Number Publication Date
FR2329275A1 true FR2329275A1 (fr) 1977-05-27
FR2329275B1 FR2329275B1 (fr) 1978-12-15

Family

ID=24509116

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7632136A Granted FR2329275A1 (fr) 1975-10-28 1976-10-25 Triazoles substitues

Country Status (12)

Country Link
JP (1) JPS5253863A (fr)
AU (1) AU1881176A (fr)
BE (1) BE847480A (fr)
DE (1) DE2648826A1 (fr)
DK (1) DK478176A (fr)
FI (1) FI763050A (fr)
FR (1) FR2329275A1 (fr)
IL (1) IL50699A0 (fr)
LU (1) LU76062A1 (fr)
NL (1) NL7611944A (fr)
NO (1) NO763569L (fr)
SE (1) SE7611884L (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005000821A1 (fr) * 2003-06-12 2005-01-06 Eli Lilly And Company Antagonistes du recepteur tachykinine
US7179804B2 (en) 2002-04-26 2007-02-20 Eli Lilly And Company Tachykinin receptor antagonists
US7320994B2 (en) 2002-04-26 2008-01-22 Eli Lilly And Company Triazole derivatives as tachykinin receptor antagonists
US9060995B2 (en) 2012-01-26 2015-06-23 Vanda Pharmaceuticals, Inc. Treatment of circadian rhythm disorders
US9730910B2 (en) 2012-12-18 2017-08-15 Vanda Pharmaceuticals, Inc. Treatment of circadian rhythm disorders
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
US11786502B2 (en) 2013-11-12 2023-10-17 Vanda Pharmaceuticals Inc. Method of treatment
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI834666A (fi) * 1982-12-23 1984-06-24 Ciba Geigy Ag Foerfarande foer framstaellning av nya aralkyltriazolfoereningar.
US4801594A (en) * 1984-06-18 1989-01-31 Eli Lilly And Company Aromatase inhibitors
CA2015267A1 (fr) * 1989-05-26 1990-11-26 Rainer Seele 8-azolylmethylquinolines
US9718789B2 (en) 2015-01-30 2017-08-01 Neurocrine Biosciences, Inc. Substituted triazoles and methods relating thereto
US9771335B2 (en) * 2015-07-31 2017-09-26 The Johns Hopkins University Derivatives of rufinamide and their use in inhibtion of the activation of human voltage-gated sodium channels
CN105801499A (zh) * 2016-04-15 2016-07-27 华东理工大学 烯酮制备新型有机oled试剂的设计及其应用
CN111196785B (zh) * 2020-01-21 2021-08-31 成都新朝阳作物科学股份有限公司 三氮唑衍生物及其制备方法和用途

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179804B2 (en) 2002-04-26 2007-02-20 Eli Lilly And Company Tachykinin receptor antagonists
US7320994B2 (en) 2002-04-26 2008-01-22 Eli Lilly And Company Triazole derivatives as tachykinin receptor antagonists
WO2005000821A1 (fr) * 2003-06-12 2005-01-06 Eli Lilly And Company Antagonistes du recepteur tachykinine
US10610510B2 (en) 2012-01-26 2020-04-07 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
US11826339B2 (en) 2012-01-26 2023-11-28 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
US9549913B2 (en) 2012-01-26 2017-01-24 Vanda Pharmaceuticals, Inc. Treatment of circadian rhythm disorders
US11918556B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
US9855241B2 (en) 2012-01-26 2018-01-02 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
US10149829B2 (en) 2012-01-26 2018-12-11 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
US10449176B2 (en) 2012-01-26 2019-10-22 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
US9060995B2 (en) 2012-01-26 2015-06-23 Vanda Pharmaceuticals, Inc. Treatment of circadian rhythm disorders
US10945988B2 (en) 2012-01-26 2021-03-16 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
US11285129B2 (en) 2012-01-26 2022-03-29 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
US11633377B2 (en) 2012-01-26 2023-04-25 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
US11850229B2 (en) 2012-01-26 2023-12-26 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
US9539234B2 (en) 2012-01-26 2017-01-10 Vanda Pharmaceuticals, Inc. Treatment of circadian rhythm disorders
US11833130B2 (en) 2012-01-26 2023-12-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
US9730910B2 (en) 2012-12-18 2017-08-15 Vanda Pharmaceuticals, Inc. Treatment of circadian rhythm disorders
US11786502B2 (en) 2013-11-12 2023-10-17 Vanda Pharmaceuticals Inc. Method of treatment
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders

Also Published As

Publication number Publication date
SE7611884L (sv) 1977-04-29
DK478176A (da) 1977-04-29
AU1881176A (en) 1978-04-27
BE847480A (fr) 1977-04-20
FR2329275B1 (fr) 1978-12-15
JPS5253863A (en) 1977-04-30
FI763050A (fr) 1977-04-29
IL50699A0 (en) 1976-12-31
LU76062A1 (fr) 1977-05-18
DE2648826A1 (de) 1977-05-05
NL7611944A (nl) 1977-05-02
NO763569L (fr) 1977-04-29

Similar Documents

Publication Publication Date Title
FR2329275A1 (fr) Triazoles substitues
DK177585A (da) Pyridazinoner
ES425786A1 (es) Procedimiento para la preparacion de nuevas indolil-piperi-dino-(o 1,2,5,6-tetrahidro-piridil)-butirofenonas.
ES418887A1 (es) Procedimiento para la produccion de derivados de 1-(4-feno-xifenil)-1,3,5 triacina.
ES8300729A1 (es) Un procedimiento para la produccion de un derivado de pripe-razina.
AU3582289A (en) Butenoic or propenoic acid derivative
IL97607A0 (en) Retinoids,their manufacture and pharmaceutical compositions containing them
GB937732A (en) New aminopyrazoles and their use
DE3462890D1 (en) Pyridazinones, their preparation and use, medicines containing these pyridazinones
TW372964B (en) Substituted 2-phenylpyridines, compositions containing same, processes for preparing same and their uses
SI0617035T1 (en) Heterotricyclic substituted phenylcyclohexanecarboxylic acid derivatives
DK0607163T3 (da) Neuroleptiske 2-substituerede perhydro-1-H-pyrido- 1,2-a pyraziner
ES335097A1 (es) Procedimiento para la obtencion de un herbicida.
ZA751662B (en) 1-(beta-d-ribofuranosyl)-1,2,24-triazole acid esters
IE32395L (en) 1,4-benzodiazepines
FR2021123A1 (fr) Nouveaux derives du 1,3-diamino-propane-2-ol
GB1555966A (en) Substituted piperidines and pyridines and their use as herbicides
FR2357251A1 (fr) 1-methyl-4-(2-carboxy-1-thioxanthan-9-ylidene)-piperidine
FR2028627A5 (en) Herbicidal 1,2,4 substd oxo-5 oxadiazoles - prepn
MY102050A (en) Imidazole anologs of mevalonolactone and derivatives thereof
ES335264A1 (es) Procedimiento para la obtencion de un herbicida.
ES2019242A6 (es) Procedimiento para preparar nuevos derivados de tieno-triazolo-diazepina.
BE802453A (fr) Derives du thiadiazole et compositions herbicides les contenant
FR2309227A1 (fr) Piperazinyl-propionamides
ATE111080T1 (de) Hydrazinderivate.

Legal Events

Date Code Title Description
ST Notification of lapse